Full text
PDF![179](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e3/434865/b7e45a0581f2/jcinvest00555-0009.png)
![180](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e3/434865/9b3a288a281d/jcinvest00555-0010.png)
![181](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e3/434865/790b8b431245/jcinvest00555-0011.png)
![182](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e3/434865/4b9eeac2af02/jcinvest00555-0012.png)
![183](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e3/434865/7531d501583b/jcinvest00555-0013.png)
![184](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e3/434865/88c6319d1aac/jcinvest00555-0014.png)
![185](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e3/434865/03622a61c2ef/jcinvest00555-0015.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bensley E. H., Ross J. B. Methaemoglobinaemia due to Sulphanilamide Therapy. Can Med Assoc J. 1937 Jul;37(1):62–64. [PMC free article] [PubMed] [Google Scholar]
- Chesley L. C. CYANOSIS WITHOUT SULF- OR METHEMOGLOBINEMIA IN PATIENTS RECEIVING SULFANILAMIDE TREATMENT. J Clin Invest. 1938 Jul;17(4):445–447. doi: 10.1172/JCI100971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hartmann A. F., Perley A. M., Barnett H. L. A STUDY OF SOME OF THE PHYSIOLOGICAL EFFECTS OF SULFANILAMIDE. II. METHEMOGLOBIN FORMATION AND ITS CONTROL. J Clin Invest. 1938 Nov;17(6):699–710. doi: 10.1172/JCI100997. [DOI] [PMC free article] [PubMed] [Google Scholar]